Health
Combination of SFRP2 and PD-1 immunotherapy halts aggressive metastatic cancer in preclinical model – News-Medical.Net
In a cancer that has not seen new targeted therapies for over 20 years, MUSC Hollings Cancer Center researcher and oncologist…
In a cancer that has not seen new targeted therapies for over 20 years, MUSC Hollings Cancer Center researcher and oncologist Nancy Klauber-DeMore, M.D., is pioneering new discoveries.
Using a combination of personal passion and expertise, Klauber-DeMore…
Continue Reading
-
Noosa News23 hours agoSerious traffic crash, Noosa – Sunshine Coast
-
Noosa News23 hours ago$20 million program to help women return to work
-
General19 hours agoAustralia’s Diamonds defeat South Africa’s Proteas 65-42 in third netball Test
-
General19 hours agoThousands join pro-Palestinian rallies in towns and cities across Australia amid ceasefire